Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective
as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid …

PURPOSE This prospective study of patients treated at the Royal Marsden Hospital
Lymphoma Unit was designed to evaluate the role of magnetic resonance imaging (MRI) in the …

Purpose To summarise data with radium-223 dichloride ( 223 RaCl 2 ), a mechanism-mediated
targeted alpha therapy (TAT), in metastatic castration-resistant prostate cancer (mCRPC) …

Objectives This was a retrospective study to assess the efficacy and morbidity of high activity
131 I therapy in patients with advanced differentiated thyroid carcinoma. Methods From …

PURPOSE: To evaluate the effects of a new microbubble contrast agent for ultrasound (US)
on breast masses. MATERIALS AND METHODS: Thirty-four patients underwent color …

It has been the aim of almost every nuclear medicine physician to develop and use the so-called
magic bullet. This would be the radiopharmaceutical of choice in tumour imaging owing …

This year marks the 75th anniversary since Saul Hertz first administered radioiodine (I-130–I-131)
to a patient on January 1st 1941 in the Massachusetts General Hospital as a treatment …

MATERIALS AND METHODS The tumor studied was a transplanted mouse sarco ma PM
implanted subcutaneously in BALB/c mice, 8-iO wk old, weighing 20— 30g, usually close to …

The aim of this paper was to compare ultrasound (US) assessment of thyroid volume with
that obtained by positron emission tomography (PET), in patients scheduled for adaptive …

Of 1116 patients receiving primary treatment for breast carcinoma at the Royal Marsden
Hospital since 1976, 651 had an abnormal bone scintigram either at primary diagnosis (378) or …